CTRI/2017/09/009841已完成未知
An Experimental Preventive trial for the assessment of non-pharmacological intervention in the management of Hypertension in a tertiary care centre of metropolitan city.
Dr Rujuta Hadaye0 个研究点目标入组 150 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •all patients with pre hypertension and stage 1 hypertension will be included
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Effect of pilocarpin on xerostomialarynx, Hypopharynx, Nasopharynx.Malignant neoplasm of larynx, Malignant neoplasm of hypopharynx, Malignant of nasopharynxc11?c13?c3IRCT2014042013167N2Shahid Sadoughi University of Medical Sciences34
已完成
不适用
A randomized clinical trial to evaluate the preventive effect of cranberry juice (UR65) for patients with recurrent urinary tract infectiorinary tract infectionJPRN-UMIN000007232Workshop of urinary tract infection300
已完成
不适用
A clinical study to evaluate the preventive effect of denosumab(Pralia) on bone loss in men receiving androgen-deprivation therapy for prostate cancer.Prostate cancerJPRN-UMIN000015127Department of Urology, Keio University School of Medicine40
招募中
1 期
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex)Kidney transplantationMedDRA version: 20.0Level: LLTClassification code: 10023438Term: Kidney transplant Class: 10042613CTIS2024-513459-34-00Medical University Of Vienna24
招募中
2 期
A prospective controlled trial to evaluate safety and efficacy of in vitro expanded recipient regulatory T cell therapy and tocilizumab together with donor bone marrow infusion in HLA-mismatched living donor kidney transplant recipients (Trex)2024-513459-34-00Medical University Of Vienna24